Evidence map›Paper›PMID 40055366›Full record

ReviewNature communications2025

Learning lessons from nano-medicine to improve the design and performances of nano-agrochemicals.

Cong Vu Thanh, J Justin Gooding, Melanie Kah

Abstract readReview
In one paragraph

Review in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Can nanozymes achieve more than enzymes?Nature reviews. Materials · 2026
    Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Cong Vu ThanhNanoSoils Bio Pty Ltd, Sydney, NSW, Australia. cong@nanosoils.com.ORCID http://orcid.org/0000-0002-4113-1862
J Justin GoodingSchool of Chemistry, University of New South Wales, Sydney, NSW, Australia. justin.gooding@unsw.edu.au.ORCID http://orcid.org/0000-0002-5398-0597
Melanie KahSchool of Environment, The University of Auckland, Auckland, New Zealand. melanie.kah@auckland.ac.nz.ORCID http://orcid.org/0000-0002-8705-9229

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sharing concepts and knowledge between medical and agricultural fields can promote the development of improved nano-enabled technologies. A central idea behind drug delivery systems is that the active substances are encapsulated in nanoparticles (nano-medicines) to protect the drugs from premature degradation and allow them to be transported to the target site within the body. After three decades of development, nano-medicines are now used in many practical applications, including clinical oncology, infectious disease, cosmetics, and vaccines. Nano-agrochemicals are increasingly considered to tackle challenges associated with food production, sustainability and food security. Despite obvious differences between nano-medicines and nano-agrochemicals in terms of uptake mechanisms, target and environmental and economic constraints, the principles behind nanoparticle design share many similarities. This article hopes to share experiences and lessons learnt from nano-medicines that will help design more effective and safer nano-agrochemicals.

Indexed as

Drug Delivery SystemsNanomedicineNanoparticlesAgricultureHumans

Identifiers

PMID40055366
PMCPMC11889108

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.